We’re one of the first firms to deliver coverage of foreign growth companies tailored specifically to U.S. investors.

Research Reports

Our research reports are available to our clients. If you are an existing client and already have a username and password, please login. If you are an existing client and want to register for access to the site, please use the registration form below.

If you are a potential client and are interested in finding out how Chardan can help you, please contact Shai Gerson at 646-465-9008.

Datesort icon Company Title Sector Symbol Rating Analyst Document
July 1, 2015 Signal Genetics, Inc. SGNL: Company Lands New Pharma Co. Customer For MyPRS Test Biotechnology & Pharmaceuticals SGNL Buy Keay Nakae, CFA Log In or Register
June 29, 2015 Marathon Update. Valuation Intriguing at Current Levels. IP Monetization JAMES McILREE, CFA Log In or Register
June 29, 2015 POZEN Inc. POZN: Our First Cut at a Pro Forma Model Healthcare POZN Buy Keay Nakae, CFA Log In or Register
June 29, 2015 Chardan Global Insights - Jun 29 2015 IPM POZN Chardan Capital Markets Research Log In or Register
June 26, 2015 Immune Pharmaceuticals, Inc. Bertilimumab moves into phase II in ulcerative colitis and bullous pemphigoid Biotechnology & Pharmaceuticals IMNP Buy Gbola Amusa, MD, CFA Log In or Register
June 26, 2015 Immune Pharmaceuticals, Inc. Chardan Global Insights - Jun 26 2015 IMNP Technology IMNP Jay Srivatsa Log In or Register
June 23, 2015 Signal Genetics, Inc. SGNL: Initiating Coverage Biotechnology & Pharmaceuticals SGNL Buy Keay Nakae, CFA Log In or Register
June 23, 2015 Chardan Global Insights - Jun 23 2015 SGNL Chardan Capital Markets Research Log In or Register
June 23, 2015 Avalanche Biotechnologies, Inc. Upgrade to Neutral, expecting limited downside from recent $15-$16 prices Biotechnology & Pharmaceuticals AAVL Neutral Gbola Amusa, MD, CFA Log In or Register
June 23, 2015 Avalanche Biotechnologies, Inc. Upgrade to Neutral, expecting limited downside from recent $15-$16 prices Biotechnology & Pharmaceuticals AAVL Neutral Gbola Amusa, MD, CFA Log In or Register

Coverage Universe

application/pdf iconResearch Universe.pdf
July 2, 2015

To learn more about our Research Group, please contact Jay Srivatsa at 646-465-9065